Bausch Health Companies (BHC) EBIT Margin Growth (3y) (2012 - 2026)
Bausch Health Companies (BHC) EBIT Margin Growth (3y) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.85 Bn | 42.88 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.02 Bn | 39.37 Bn | 2.15 Bn | 1,129.00 |
| 3 | Zoetis | 31.47 Bn | 29.79 Bn | 1.05 Bn | 2.00 |
| 4 | Takeda Pharmaceutical | 28.59 Bn | 22.79 Bn | 5.10 Bn | 59.00 |
| 5 | United Therapeutics | 22.20 Bn | 19.53 Bn | 683.80 Mn | -1,031.00 |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn | -925.00 |
| 7 | Neurocrine Biosciences | 15.45 Bn | 15.06 Bn | 935.80 Mn | -46.00 |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 6,666.00 |
| 9 | Dr Reddys Laboratories | 10.10 Bn | 9.94 Bn | - | - |
| 10 | Bausch Health Companies | 2.57 Bn | 730.75 Mn | 2.10 Bn | 693.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 693.00 |
| Mar 31, 2026 | -4,664.00 |
| Dec 31, 2025 | 2,771.00 |
| Sep 30, 2025 | 1,116.00 |
| Jun 30, 2025 | 936.00 |
| Mar 31, 2025 | -264.00 |
| Dec 31, 2024 | 1,674.00 |
| Sep 30, 2024 | -1,452.00 |
| Jun 30, 2024 | 2,905.00 |
| Mar 31, 2024 | 2,395.00 |
| Dec 31, 2023 | 1,526.00 |
| Sep 30, 2023 | -2,089.00 |
| Jun 30, 2023 | 2,064.00 |
| Mar 31, 2023 | -332.00 |
| Dec 31, 2022 | 3,762.00 |
| Sep 30, 2022 | -297.00 |
| Jun 30, 2022 | -376.00 |
| Mar 31, 2022 | 62.00 |
| Dec 31, 2021 | 389.00 |
| Sep 30, 2021 | 2,171.00 |